Insider Transactions Reported by 18 Insiders of IDEAYA Biosciences, Inc.

Symbol
IDYA on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

IDEAYA Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Yujiro S. Hata President and CEO, Director $13,482,366 30 Jan 2026
Michael P. Dillon SVP, Chief Scientific Officer $3,311,116 04 Oct 2021
Jeffrey Stein Director $1,909,511 +$1,647,890 +630% 02 Mar 2026
Briseno Andres Ruiz Title: SVP, Head of Finance and Investor Relations $447,447 30 Jan 2026
Jason Throne Chief Legal Officer $445,023 27 Jun 2024
Paul A. Stone Chief Financial Officer $390,960 29 Aug 2023
Douglas B. Snyder SVP, General Counsel $35,165 30 Jan 2026
STUART DORMAN Chief Commercial Officer 30 Jan 2026
TIMOTHY M. SHANNON Director 07 Jun 2023
Darrin Beaupre Chief Medical Officer 30 Jan 2026
Scott W. Morrison Director 24 Jun 2025
MICHAEL ANTHONY WHITE Chief Scientific Officer 30 Jan 2026
Susan L. Kelley Director 31 May 2024
Joshua Bleharski Chief Financial Officer 30 Jan 2026
CATHERINE J. MACKEY Director 24 Jun 2025
Malcolm Garret Hampton Director 24 Jun 2025
WENDY L. YARNO Director 24 Jun 2025
TERRY J. ROSEN Director 24 Jun 2025

Recent Insider Transactions by Companies or Individuals for IDEAYA Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.